“We don’t want special treatment, just that Swiss products are treated the same as those from any other third country to the EU.” So said Swiss Medtech regulatory head Daniel Delfosse, who fears that EU market access will be made much more difficult, if not impossible for some local companies, after the Medical Device Regulation comes into force in the EU on 26 May.
The ongoing failure of two parties to renew the mutual recognition agreement (MRA) to take account of the new medtech regulatory conditions that the MDR enforces will lead to blocked...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?